Reaction
Vogt-Koyanagi-Harada Disease reporting signals
As of the last recalculation, Vogt-Koyanagi-Harada Disease appears in 212 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is DABRAFENIB (PRR 131.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dabrafenib | 25 | 131.9 | 132.1 |
| Trametinib | 25 | 115.0 | 115.1 |
| Ipilimumab | 34 | 91.9 | 92.0 |
| Encorafenib | 8 | 82.4 | 82.5 |
| Nivolumab | 58 | 80.7 | 80.8 |
| Rifampin | 11 | 78.0 | 78.0 |
| Vemurafenib | 4 | 33.3 | 33.3 |
| Salicylic Acid | 4 | 7.5 | 7.5 |